Search
This research paper (available here in pdf form), which was published in Journal of Pharmaceutical Health Services Research in March 2020. State Pharmaceutical Importation Programmes: an Analysis of the Cost‐Effectiveness Author: Dr. Kristina M.L. Acri née Lybecker, Senior Fellow at the Fraser Institute and Associate Professor of Economics at Colorado College in Colorado Springs Abstract: This article examines the cost‐effectiveness of…
Read MoreResearch Study Confirms That Cheap And Safe Drug Importation Is Not Feasible Read the abstract for Dr. Acri’s article. In March 2020, the Journal of Pharmaceutical Health Services Research, an official journal of the Royal Pharmaceutical Society, published a study by Dr. Kristina M.L. Acri née Lybecker titled “State Pharmaceutical Importation Programmes: An Analysis of the Cost-effectiveness.” In the paper,…
Read More
Even as the COVID-19 pandemic unfolds, PSM is keeping a steady eye on public reports of dangerous counterfeit drugs. Here’s a quick round-up of counterfeit news published the week of April 27th, 2020.
Read MoreIn June 2019, the governor of Maine signed into law LD 1272, a bill that would allow the state to establish a wholesale Canadian prescription drug importation program. On April 13, 2020, the Partnership for Safe Medicines (PSM) filed a request to receive copies of all submitted responses to Maine’s Request for Comment (RFC) for the proposed wholesale prescription drug…
Read More
The FDA was established to protect Americans from adulterated food and medicines and from criminals selling ineffective, outrageous, and sometimes harmful treatments. Unfortunately, fake cures are fertile ground for profiteers, and no matter how many products the FDA seizes, more crop up. In the wake of the COVID-19 pandemic the FDA has been working overtime to stop the sale of harmful and ineffective COVID “treatments.” This week PSM did some research in the FDA’s warning letter archives to survey fake COVID-19 cures.
Read More
In this edition: Senators take up ASOP’s Call To Arms on domain name scams, more fake test kits, and the nearly infinite pool of #covidscam domain names.
Read More
In this edition: ASOP letter to the White House, more fake test kits and treatments and HR 5663, the Safeguarding Therapeutics Act
Read More
In a letter dated April 9th, the Alliance for Safe Online Pharmacies (ASOP) has requested that the Vice President prioritize evidence-based messaging and focus energies on provable therapies for treating COVID-19. The letter also asks the Vice President to address the “systemic, structural Internet policy problems that enable COVID-19 scams online.”
Read More
Testing medicine for legitimacy is a complicated process. Across 24 different prescription medicines, the average cost to test a single dose is $2,750. However, ensuring that a batch of 100 pills is 90% certain to be safe requires testing at least 22 pills. Achieving 99.999% certainty requires even more testing, at tremendous expense. To learn more about this topic, read PSM’s summary: safedr.ug/Acri-Explained.
Read More
The Los Angeles City Attorney’s Office is being kept very busy trying to shut down LA area COVID-19 testing schemes that being offered without FDA or local health department approval.
Read More